Company Consun Pharmaceutical Group Limited Deutsche Boerse AG

Equities

C1P

KYG2524A1031

Pharmaceuticals

Market Closed - Deutsche Boerse AG 10:54:49 2024-05-24 EDT 5-day change 1st Jan Change
0.76 EUR +14.29% Intraday chart for Consun Pharmaceutical Group Limited +11.76% +43.40%

Business Summary

Consun Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Company’s subsidiaries include Brilliant Reach Group Limited, Century International Develop Limited and Grand Reach Company Limited. Through its subsidiaries, the Company is also engaged in the research and development of pharmaceutical products.

Number of employees: 3,127

Sales per Business

HKD in Million2022Weight2023Weight Delta
Kidney Medicines
67.2 %
1,825 67.1 % 1,924 67.2 % +5.43%
Gynaecology and Paediatrics Drugs
11.3 %
278 10.2 % 325 11.3 % +16.58%
Contrast Medium
6.0 %
190 7.0 % 172 6.0 % -9.34%
Orthopedics Medicines
5.9 %
204 7.5 % 169 5.9 % -16.83%
Dermatologic Medicines
5.0 %
134 4.9 % 142 5.0 % +6.00%
Hepatobiliary Medicines
3.1 %
54 2.0 % 88 3.1 % +62.55%
Others
1.5 %
36 1.3 % 43 1.5 % +17.60%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
2,721 100.0 % 2,862 100.0 % +5.20%

Managers

Managers TitleAgeSince
Chief Executive Officer 52 21-03-23
Director of Finance/CFO 45 10-07-31
Director/Board Member 30 20-10-31
Director/Board Member 44 13-04-30
Corporate Secretary 56 -
Corporate Secretary 56 13-02-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 84 12-12-23
Director/Board Member 65 13-12-01
Director/Board Member 44 13-04-30
Chief Executive Officer 52 21-03-23
Director/Board Member 30 20-10-31
Director/Board Member 47 21-07-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 817,901,427 349,439,073 ( 42.72 %) 0 42.72 %

Shareholders

NameEquities%Valuation
Yu Bao An
26.72 %
216,956,455 26.72 % 162 M €
Qian Li
17.90 %
145,362,899 17.90 % 109 M €
110,050,000 13.55 % 82 M €
Meng An
1.790 %
14,531,000 1.790 % 11 M €
AllianceBernstein Ltd.
0.3802 %
3,087,000 0.3802 % 2 M €
Fullgoal Fund Management Co., Ltd.
0.3068 %
2,491,000 0.3068 % 2 M €
Lacuna Vermögen GmbH
0.3006 %
2,441,000 0.3006 % 2 M €
Nomura Asset Management (Hong Kong) Ltd.
0.1241 %
1,007,628 0.1241 % 753 676 €
Dimensional Fund Advisors Ltd.
0.0622 %
505,026 0.0622 % 377 744 €
Nomura Asset Management Singapore Ltd.
0.0548 %
444,954 0.0548 % 332 812 €

Company contact information

Consun Pharmaceutical Group Ltd.

71 Dong Peng Avenue, Eastern Section Guangzhou Economic & Technological

510760, Guangzhou

+86 20 8226 4529

http://www.chinaconsun.com
address Consun Pharmaceutical Group Limited(C1P)

Sales per Business

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.192 CNY
Average target price
7.272 CNY
Spread / Average Target
+17.43%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1681 Stock
  4. C1P Stock
  5. Company Consun Pharmaceutical Group Limited